Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor antigens recognized by T lymphocytes

T Boon1, J C Cerottini, B Van den Eynde

  • 1Ludwig Institute for Cancer Research, Brussels, Belgium.

Annual Review of Immunology
|January 1, 1994
PubMed
Summary

Researchers identified specific tumor antigens recognized by T lymphocytes, paving the way for targeted cancer immunotherapy. This discovery advances the field of cancer immunology and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium.

Arthritis and rheumatism·2011
Same author

[Is it possible to correct the anergy of T lymphocytes that infiltrate tumors?].

Bulletin et memoires de l'Academie royale de medecine de Belgique·2010
Same author

[Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].

Bulletin et memoires de l'Academie royale de medecine de Belgique·2008
Same author

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.

Gene therapy·2005
Same author

A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.

Leukemia·2004

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor antigens are recognized by T lymphocytes, mediating rejection responses in mice.
  • Human tumor-specific cytolytic T cell (CTL) clones have been generated using autologous cultures.

Purpose of the Study:

  • To identify target antigens on human tumors recognized by autologous CTLs.
  • To explore novel approaches for cancer immune therapy.

Main Methods:

  • Biochemical fractionation of tumor cells.
  • Gene transfection techniques.
  • Generation of cytolytic T cell (CTL) clones from autologous cultures.

Main Results:

  • Underglycosylated mucins identified on breast and pancreatic carcinomas.

Related Experiment Videos

  • MAGE gene family identified, coding for antigens recognized on melanoma.
  • Differentiation antigens like tyrosinase also recognized on human melanoma.

    • Conclusions:

    • Identification of human tumor rejection antigens enables systematic approaches to specific immune therapy.
    • MAGE genes and differentiation antigens represent promising targets for cancer vaccines and therapies.